45P Efficacy of derazantinib in intrahepatic cholangiocarcinoma patients with FGFR2 mutations or amplifications: Pooled analysis of clinical trials and early access programs
Titel:
45P Efficacy of derazantinib in intrahepatic cholangiocarcinoma patients with FGFR2 mutations or amplifications: Pooled analysis of clinical trials and early access programs
Auteur:
Droz Dit Busset, M. Shaib, W.L. Harris, W.P. Damjanov, N. Borad, M. Vogel, A. Bridgewater, J.A. Sellmann, L. Dadduzio, V. Borner, M. Snider, J. Cantero, F. Saulay, M. Braun, S. Mazzaferro, V. Javle, M.